Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01977495 · ClinicalTrials.gov registry record · NA

Take Charge of Your Diabetes

A NA study of Hypertension and Diabetes, sponsored by University of Pennsylvania.

Completed
Registry status
NA
Development phase
136
Enrollment target
1
Study location

NCT01977495 is a NA study of Hypertension and Diabetes that has completed, run by University of Pennsylvania. The registered enrollment target is 136 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01977495, a NA study of Hypertension and Diabetes, has completed, sponsored by University of Pennsylvania.

COMPLETED
Registry status
NA
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

The investigator plans to assess enrollment rates among two different enrollment methods, while providing a behavioral economic intervention to enhance the uptake of home-health monitoring devices to lower hemoglobin A1C among patients with uncontrolled diabetes. The study is focusing on enrollment methods since the standard randomized control trial only reaches 15% of the population. The study is seeking to understand the effectiveness of a behavioral intervention, when rolled out in a larger population.

Conditions Studied

Interventions

  • BEHAVIORAL Financial Incentive: Fixed Lottery

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2013-12
Est. Completion 2014-08
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT01977495

The ClinicalTrials.gov registry entry for NCT01977495 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Financial Incentive: Fixed Lottery is the first listed.

NCT01977495 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01977495 about?

NCT01977495 is a clinical study titled "Take Charge of Your Diabetes". The investigator plans to assess enrollment rates among two different enrollment methods, while providing a behavioral economic intervention to enhance the uptake of home-health monitoring devices to lower hemoglobin A1C among patients with uncontrolled diabetes. The study is focusing on enrollment ...

What is the current status of trial NCT01977495?

This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2013-12. Estimated completion is 2014-08.

What conditions does trial NCT01977495 study?

This clinical trial studies the following conditions: Hypertension, Diabetes.

What interventions are being tested in trial NCT01977495?

The interventions under investigation include: Financial Incentive: Fixed Lottery (BEHAVIORAL).

Who is sponsoring clinical trial NCT01977495?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01977495 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.